A registered study indexed because it matched monitored longevity research terms. Registry status: Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- NA · SINGLE GROUP · SCREENING · NONE
- Evidence population
- Human clinical study registration
- Participants
- 20
- Population
- ALL · 75 Years
- Duration
- 2026-08-17 to 2028-08-17
- Intervention
- Total hip replacement; Blood sampling; Muscle biopsies; Collection of joint samples derived from surgical waste; DXA; MRI; Handgrip strength test
- Comparator
- Not reported
- Outcomes measured
- Change from Baseline in the Barthel Index at 3 months post-operative — Baseline and 3 months; Change from Baseline in the Barthel Index at 6 months post-operative — Baseline and 6 months; Measurement of hand-grip strength via dynamometry — Baseline; Measurement of appendicular lean mass by DXA — Prior to surgery or within 7 days postoperatively; Measurement of quadriceps mass by MRI — Prior to surgery or within 7 days postoperatively; Number of myoblastic progenitors at proliferation onset — Intraoperative; Mean myotube surface area at differentiation end — Intraoperative; Proportion of senescent MSCs — Intraoperative; Number of chondrocytes obtained from MSCs at differentiation end — Intraoperative; Number of adipocytes obtained from MSCs at differentiation end — Intraoperative; Number of osteocytes obtained from MSCs at differentiation end. — Intraoperative; Serum concentation of myostatin — Baseline and 3 month; Serum concentation of myostatin — Baseline and 6 month; Serum concentation of follistatin — Baseline and 3 month; Serum concentation of follistatin — Baseline and 6 month; Serum concentation of irisin — Baseline and 3 month; Serum concentation of irisin — Baseline and 6 month; Serum concentation of IL-6 — Baseline and 3 month; Serum concentation of IL-6 — Baseline and 6 month; Serum concentation of IGF-1 — Baseline and 3 month
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.